ArticleBlood cancer journal2026

Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.

Sanjal H Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.